Form EFFECT Monopar Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 9, 2025 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SAS named a Leader in worldwide decision intelligence platforms
- HON Launches Scribble, a Flexible Polyshell Classroom Chair with Built-in Tactile Feature for K-12 Student Engagement
- Hunt Capital Partners Closes Financing to Rehabilitate Two Four-Story 1923 Buildings into a 55-Unit Affordable Housing Community in Kansas City, Missouri
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
